Laurent Chardonnet - 21 Dec 2022 Form 4 Insider Report for Prelude Therapeutics Inc (PRLD)

Role
Chief Financial Officer
Signature
/s/ Laurent Chardonnet
Issuer symbol
PRLD
Transactions as of
21 Dec 2022
Transactions value $
$0
Form type
4
Filing time
22 Dec 2022, 15:05:00 UTC
Previous filing
12 Dec 2022
Next filing
09 Feb 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PRLD Employee Stock Option (right to buy) Award $0 +75K $0.00 75K 21 Dec 2022 Common Stock 75K $4.90 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests as to 25% of the total shares on December 21, 2023, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.